首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1798132

2025-2029年全球红色生物技术市场

Global Red Biotechnology Market 2025-2029

出版日期: 2025年08月14日 | 出版商:

TechNavio | 英文 215 Pages | 订单完成后即时交付

价格

简介目录图表

预计 2024 年至 2029 年间红色生技市场规模将达 2,543 亿美元，预测期内复合年增长率为 7%。

本报告对红色生物技术市场进行了全面的分析，包括市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。市场受到基因组学研究的进步、慢性病盛行率的增加以及全球人口老化的推动。

市场覆盖
基准年	2025
年底	2029
预测期	2025-2029
成长动力	加速度
同比	6.6%
复合年增长率	7%
增量金额	2543亿美元

这项研究客观地结合了一手和二手讯息，并纳入了行业主要参与者的意见。报告包含对主要企业的分析，以及全面的市场规模数据、区域细分和供应商格局。报告包含历史数据和预测数据。

研究指出，干细胞研究和治疗的兴起是未来几年推动红色生物技术市场成长的关键因素之一。此外，生物製药和治疗性蛋白质产量的增加，以及生物资讯学和数据分析应用的不断普及，也将带来庞大的市场需求。

市场区隔
比较：按产品
单株抗体：2024 年至 2029 年市场规模及预测
基因治疗：市场规模及预测（2024-2029）
多株抗体：市场规模及预测（2024-2029）
细胞免疫疗法产品：2024 年至 2029 年市场规模及预测
其他：2024-2029 年市场规模及预测
按产品分類的市场机会

9. 按最终用户细分的市场

市场区隔
比较：按最终用户
製药和生物技术公司：2024-2029 年市场规模和预测
CMO 与 CRO 市场规模及预测（2024-2029）
学术研究：市场规模及预测 2024-2029
最终用户的市场机会

第十章市场区隔诊断方法

市场区隔
比较：依诊断方法
分子诊断：2024-2029 年市场规模及预测
免疫检测：市场规模与预测 2024-2029
NGS：市场规模及预测（2024-2029）
诊断方法的市场机会

第十一章客户情况

客户概览

第十二章地区情势

区域细分
区域比较
北美：市场规模及预测 2024-2029
欧洲：2024-2029 年市场规模及预测
亚洲：2024-2029 年市场规模及预测
世界其他地区：2024 年至 2029 年市场规模及预测
美国：市场规模与预测 2024-2029
德国：2024-2029年市场规模及预测
中国：市场规模及预测（2024-2029）
加拿大：市场规模及预测（2024-2029）
英国：市场规模及预测 2024-2029
印度：市场规模及预测（2024-2029）
法国：2024-2029年市场规模及预测
日本：2024-2029 年市场规模及预测
义大利：2024-2029 年市场规模及预测
韩国：市场规模及预测（2024-2029）
各地区市场机会

第十三章驱动因素、挑战、机会与限制因素

市场驱动因素
市场挑战
驱动因素和挑战的影响
市场机会与限制

第十四章竞争格局

概述
竞争格局
令人困惑的情况
产业风险

第十五章竞争分析

公司简介
企业排名指数
公司市场定位
Amgen Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Bayer AG
Biogen Inc.
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
Merck KGaA
Novartis AG
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
STEMCELL Technologies Inc.
Teva Pharmaceutical Industries Ltd.

第十六章附录

简介目录图表

Product Code: IRTNTR76970

The red biotechnology market is forecasted to grow by USD 254.3 bn during 2024-2029, accelerating at a CAGR of 7% during the forecast period. The report on the red biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in genomic research, increase in prevalence of chronic diseases, and growing aging population globally.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.6%
CAGR	7%
Incremental Value	$254.3 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's red biotechnology market is segmented as below:

By Product

Monoclonal antibodies
Gene therapy
Polyclonal antibodies
Cell-based immunotherapy products
Others

By End-user

Pharmaceutical and biotechnology companies
CMOs and CROs
Academic research institutes

By Diagnostic Methods

Molecular diagnostics
Immunoassays
NGS

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising STEM cell research and therapies as one of the prime reasons driving the red biotechnology market growth during the next few years. Also, increasing production of biopharmaceuticals and therapeutic proteins and rising prevalence of bioinformatics and data analytics will lead to sizable demand in the market.

The report on the red biotechnology market covers the following areas:

Red Biotechnology Market sizing
Red Biotechnology Market forecast
Red Biotechnology Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading red biotechnology market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.. Also, the red biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Red Biotechnology Market 2019 - 2023
- Historic Market Size - Data Table on Global Red Biotechnology Market 2019 - 2023 ($ billion)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
5.4 Diagnostic Methods segment analysis 2019 - 2023
- Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI in the global red biotechnology market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Monoclonal antibodies - Market size and forecast 2024-2029
- Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
8.4 Gene therapy - Market size and forecast 2024-2029
- Chart on Gene therapy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Gene therapy - Market size and forecast 2024-2029 ($ billion)
- Chart on Gene therapy - Year-over-year growth 2024-2029 (%)
- Data Table on Gene therapy - Year-over-year growth 2024-2029 (%)
8.5 Polyclonal antibodies - Market size and forecast 2024-2029
- Chart on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Chart on Polyclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Polyclonal antibodies - Year-over-year growth 2024-2029 (%)
8.6 Cell-based immunotherapy products - Market size and forecast 2024-2029
- Chart on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion)
- Data Table on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion)
- Chart on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%)
- Data Table on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
- Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion)
- Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.4 CMOs and CROs - Market size and forecast 2024-2029
- Chart on CMOs and CROs - Market size and forecast 2024-2029 ($ billion)
- Data Table on CMOs and CROs - Market size and forecast 2024-2029 ($ billion)
- Chart on CMOs and CROs - Year-over-year growth 2024-2029 (%)
- Data Table on CMOs and CROs - Year-over-year growth 2024-2029 (%)
9.5 Academic research institutes - Market size and forecast 2024-2029
- Chart on Academic research institutes - Market size and forecast 2024-2029 ($ billion)
- Data Table on Academic research institutes - Market size and forecast 2024-2029 ($ billion)
- Chart on Academic research institutes - Year-over-year growth 2024-2029 (%)
- Data Table on Academic research institutes - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)

10 Market Segmentation by Diagnostic Methods

10.1 Market segments
- Chart on Diagnostic Methods - Market share 2024-2029 (%)
- Data Table on Diagnostic Methods - Market share 2024-2029 (%)
10.2 Comparison by Diagnostic Methods
- Chart on Comparison by Diagnostic Methods
- Data Table on Comparison by Diagnostic Methods
10.3 Molecular diagnostics - Market size and forecast 2024-2029
- Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion)
- Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%)
- Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%)
10.4 Immunoassays - Market size and forecast 2024-2029
- Chart on Immunoassays - Market size and forecast 2024-2029 ($ billion)
- Data Table on Immunoassays - Market size and forecast 2024-2029 ($ billion)
- Chart on Immunoassays - Year-over-year growth 2024-2029 (%)
- Data Table on Immunoassays - Year-over-year growth 2024-2029 (%)
10.5 NGS - Market size and forecast 2024-2029
- Chart on NGS - Market size and forecast 2024-2029 ($ billion)
- Data Table on NGS - Market size and forecast 2024-2029 ($ billion)
- Chart on NGS - Year-over-year growth 2024-2029 (%)
- Data Table on NGS - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Diagnostic Methods
- Market opportunity by Diagnostic Methods ($ billion)
- Data Table on Market opportunity by Diagnostic Methods ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.5 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.7 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.8 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings
- SWOT
15.9 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.10 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.12 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
15.13 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.16 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
15.17 STEMCELL Technologies Inc.
- STEMCELL Technologies Inc. - Overview
- STEMCELL Technologies Inc. - Product / Service
- STEMCELL Technologies Inc. - Key offerings
- SWOT
15.18 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

简介目录图表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Red Biotechnology Market 2019 - 2023 ($ billion)
Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ billion)
Exhibits27: Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
Exhibits28: Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ billion)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product - Market share 2024-2029 (%)
Exhibits39: Data Table on Product - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product
Exhibits41: Data Table on Comparison by Product
Exhibits42: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
Exhibits43: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
Exhibits44: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Gene therapy - Market size and forecast 2024-2029 ($ billion)
Exhibits47: Data Table on Gene therapy - Market size and forecast 2024-2029 ($ billion)
Exhibits48: Chart on Gene therapy - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Gene therapy - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion)
Exhibits51: Data Table on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion)
Exhibits52: Chart on Polyclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Polyclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits54: Chart on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion)
Exhibits55: Data Table on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion)
Exhibits56: Chart on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Product ($ billion)
Exhibits63: Data Table on Market opportunity by Product ($ billion)
Exhibits64: Chart on End-user - Market share 2024-2029 (%)
Exhibits65: Data Table on End-user - Market share 2024-2029 (%)
Exhibits66: Chart on Comparison by End-user
Exhibits67: Data Table on Comparison by End-user
Exhibits68: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion)
Exhibits69: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion)
Exhibits70: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on CMOs and CROs - Market size and forecast 2024-2029 ($ billion)
Exhibits73: Data Table on CMOs and CROs - Market size and forecast 2024-2029 ($ billion)
Exhibits74: Chart on CMOs and CROs - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on CMOs and CROs - Year-over-year growth 2024-2029 (%)
Exhibits76: Chart on Academic research institutes - Market size and forecast 2024-2029 ($ billion)
Exhibits77: Data Table on Academic research institutes - Market size and forecast 2024-2029 ($ billion)
Exhibits78: Chart on Academic research institutes - Year-over-year growth 2024-2029 (%)
Exhibits79: Data Table on Academic research institutes - Year-over-year growth 2024-2029 (%)
Exhibits80: Market opportunity by End-user ($ billion)
Exhibits81: Data Table on Market opportunity by End-user ($ billion)
Exhibits82: Chart on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits83: Data Table on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits84: Chart on Comparison by Diagnostic Methods
Exhibits85: Data Table on Comparison by Diagnostic Methods
Exhibits86: Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion)
Exhibits87: Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion)
Exhibits88: Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Immunoassays - Market size and forecast 2024-2029 ($ billion)
Exhibits91: Data Table on Immunoassays - Market size and forecast 2024-2029 ($ billion)
Exhibits92: Chart on Immunoassays - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Immunoassays - Year-over-year growth 2024-2029 (%)
Exhibits94: Chart on NGS - Market size and forecast 2024-2029 ($ billion)
Exhibits95: Data Table on NGS - Market size and forecast 2024-2029 ($ billion)
Exhibits96: Chart on NGS - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on NGS - Year-over-year growth 2024-2029 (%)
Exhibits98: Market opportunity by Diagnostic Methods ($ billion)
Exhibits99: Data Table on Market opportunity by Diagnostic Methods ($ billion)
Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits103: Chart on Geographic comparison
Exhibits104: Data Table on Geographic comparison
Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits142: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits158: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits159: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits161: Market opportunity By Geographical Landscape ($ billion)
Exhibits162: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits163: Impact of drivers and challenges in 2024 and 2029
Exhibits164: Overview on criticality of inputs and factors of differentiation
Exhibits165: Overview on factors of disruption
Exhibits166: Impact of key risks on business
Exhibits167: Companies covered
Exhibits168: Company ranking index
Exhibits169: Matrix on companies position and classification
Exhibits170: Amgen Inc. - Overview
Exhibits171: Amgen Inc. - Product / Service
Exhibits172: Amgen Inc. - Key news
Exhibits173: Amgen Inc. - Key offerings
Exhibits174: SWOT
Exhibits175: Astellas Pharma Inc. - Overview
Exhibits176: Astellas Pharma Inc. - Product / Service
Exhibits177: Astellas Pharma Inc. - Key offerings
Exhibits178: SWOT
Exhibits179: AstraZeneca Plc - Overview
Exhibits180: AstraZeneca Plc - Product / Service
Exhibits181: AstraZeneca Plc - Key news
Exhibits182: AstraZeneca Plc - Key offerings
Exhibits183: SWOT
Exhibits184: Bayer AG - Overview
Exhibits185: Bayer AG - Business segments
Exhibits186: Bayer AG - Key news
Exhibits187: Bayer AG - Key offerings
Exhibits188: Bayer AG - Segment focus
Exhibits189: SWOT
Exhibits190: Biogen Inc. - Overview
Exhibits191: Biogen Inc. - Product / Service
Exhibits192: Biogen Inc. - Key offerings
Exhibits193: SWOT
Exhibits194: Boehringer Ingelheim International GmbH - Overview
Exhibits195: Boehringer Ingelheim International GmbH - Product / Service
Exhibits196: Boehringer Ingelheim International GmbH - Key news
Exhibits197: Boehringer Ingelheim International GmbH - Key offerings
Exhibits198: SWOT
Exhibits199: Bristol Myers Squibb Co. - Overview
Exhibits200: Bristol Myers Squibb Co. - Product / Service
Exhibits201: Bristol Myers Squibb Co. - Key news
Exhibits202: Bristol Myers Squibb Co. - Key offerings
Exhibits203: SWOT
Exhibits204: F. Hoffmann La Roche Ltd. - Overview
Exhibits205: F. Hoffmann La Roche Ltd. - Business segments
Exhibits206: F. Hoffmann La Roche Ltd. - Key news
Exhibits207: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits208: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits209: SWOT
Exhibits210: Gilead Sciences Inc. - Overview
Exhibits211: Gilead Sciences Inc. - Product / Service
Exhibits212: Gilead Sciences Inc. - Key news
Exhibits213: Gilead Sciences Inc. - Key offerings
Exhibits214: SWOT
Exhibits215: Merck KGaA - Overview
Exhibits216: Merck KGaA - Business segments
Exhibits217: Merck KGaA - Key news
Exhibits218: Merck KGaA - Key offerings
Exhibits219: Merck KGaA - Segment focus
Exhibits220: SWOT
Exhibits221: Novartis AG - Overview
Exhibits222: Novartis AG - Business segments
Exhibits223: Novartis AG - Key news
Exhibits224: Novartis AG - Key offerings
Exhibits225: Novartis AG - Segment focus
Exhibits226: SWOT
Exhibits227: Pfizer Inc. - Overview
Exhibits228: Pfizer Inc. - Product / Service
Exhibits229: Pfizer Inc. - Key news
Exhibits230: Pfizer Inc. - Key offerings
Exhibits231: SWOT
Exhibits232: Regeneron Pharmaceuticals Inc. - Overview
Exhibits233: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits234: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits235: SWOT
Exhibits236: STEMCELL Technologies Inc. - Overview
Exhibits237: STEMCELL Technologies Inc. - Product / Service
Exhibits238: STEMCELL Technologies Inc. - Key offerings
Exhibits239: SWOT
Exhibits240: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits241: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits242: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits243: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits244: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits245: SWOT
Exhibits246: Inclusions checklist
Exhibits247: Exclusions checklist
Exhibits248: Currency conversion rates for US$
Exhibits249: Research methodology
Exhibits250: Information sources
Exhibits251: Data validation
Exhibits252: Validation techniques employed for market sizing
Exhibits253: Data synthesis
Exhibits254: 360 degree market analysis
Exhibits255: List of abbreviations

02-2729-4219

+886-2-2729-4219

License/价格

2025-2029年全球红色生物技术市场

Global Red Biotechnology Market 2025-2029

目录

第一章执行摘要

第二章 Technavio 分析

第三章市场状况

第四章市场规模

第五章市场规模表现

第六章定性分析

第七章五力分析

第八章按产品细分市场